We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Reckitt Benckiser Group Plc (RKT) Ord 10p

Sell:4,802.00p Buy:4,805.00p 0 Change: 12.00p (0.25%)
FTSE 100:0.26%
Market closed Prices as at close on 20 December 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:4,802.00p
Buy:4,805.00p
Change: 12.00p (0.25%)
Market closed Prices as at close on 20 December 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:4,802.00p
Buy:4,805.00p
Change: 12.00p (0.25%)
Market closed Prices as at close on 20 December 2024 Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

HL comment (23 October 2024)

No recommendation - No news or research item is a personal recommendation to deal. All investments can fall as well as rise in value so you could get back less than you invest.

Reckitt reported third-quarter net revenue of £3.5bn, down 0.5% on a like-for-like (LFL) basis. Within that, volumes dropped 1.4%, better than the 3.1% drop that was expected, with pricing giving a 0.9% positive offset.

Hygiene and Health delivered both volume and price growth led by Lysol, Gaviscon, Durex and VMS. The Nutrition business saw LFL sales down 17.4%, as supply to customers was impacted by the Mount Vernon tornado – though this wasn’t as bad as expected.

Full-year targets are unchanged, pointing to LFL net revenue growth of 1-3%.

The shares rose 3.5% in early trading.

Our view

Reckitt is the maker of household and hygiene staples like Air Wick, Harpic, and Vanish. Third quarter results were better than expected but flattered somewhat by the impact of a tornado in Mount Vernon not being as bad as first thought. Despite the one-off nature of the beat, management still gave an upbeat tone on underlying performance.

Aside from the numbers, there’s a strategy shift underway. Several ‘non-core’ home care brands are on the chopping block. This isn’t a small reshuffle either, together they account for around 13% of annual sales. Streamlining makes sense, but there will be execution risk.

As the biggest contributor to sales, it's good to see volumes in Hygiene trending back in the right direction. Investors have been looking for a better balance between volume and price led growth and it looks like we might have reached the inflection point where things start improving. Competition in this segment is tough, and we’d like to see improved performance vs peers over the second half.

Nutrition's the smallest division but has continued to be a volume drag. Last year's sales were inflated by competitors' supply issues, and as they come back to market, Reckitt's giving back some of the market share it gained. Then the tornado’s caused more recent issues, but this unit is expected to be back on track in 6-9 months.

Portfolio changes, along with cost cuts, have helped gross margins return to historic levels. While we’re happy to see progress, there’s a slight worry that a focus on costs and gross margins is a temporary fix. To sustain longer term growth, we’d like to see more of a focus on finding new distribution and increasing market share.

The balance sheet's in reasonable health, and with £2.0bn of expected free cash this year the fresh £1bn buyback and 4.4% yield is well supported. Of course, no returns are guaranteed.

Perhaps the biggest risk lies with its US subsidiary, Mead Johnson. There are hundreds of ongoing court cases in the US relating to its infant baby formula. After some setbacks, recent news appears to be more positive, but this will drive near term sentiment. This business has been classified as ‘non-core’ as part of the new strategy, and a range of options are being discussed.

With a new strategy and a valuation that doesn't look overly demanding, Reckitt looks attractive from here. But court rulings in the US will be key and meaningful volume recovery isn't expected until later in the year, which means investors should be prepared to wait for the tide to turn.

Environmental, social, and governance (ESG) risk

The retail industry is low/medium in terms of ESG risk but varies by subsector. Online retailers are the most exposed, as are companies based in the Asia-Pacific region. The growing demand for transparency and accountability means human rights and environmental risks within supply chains have become a key risk driver. The quality and safety of products as well as their impact on society and the environment are also important considerations.

According to Sustainalytics, Reckitt’s overall management of material ESG issues is strong.

Reckitt’s corporate responsibility committee oversees its ESG strategy, with progress reported in the annual Sustainability Insights Report, focusing on 19 areas like ethical business, product safety, and waste management. The company has strong anti-bribery policies and initiatives, including regular employee training and external audits, to ensure product safety. However, gaps in reporting persist, particularly around external quality management certification for Reckitt’s sites and suppliers.

Reckitt key facts

  • Forward price/earnings ratio (next 12 months): 14.3

  • Ten year average forward price/earnings ratio: 19.4

  • Prospective dividend yield (next 12 months): 4.4%

  • Ten year average prospective dividend yield: 2.8%

All ratios are sourced from Refinitiv, based on previous day’s closing values. Please remember yields are variable and not a reliable indicator of future income. Keep in mind key figures shouldn’t be looked at on their own – it’s important to understand the big picture.

This article is original Hargreaves Lansdown content, published by Hargreaves Lansdown. It was correct as at the date of publication, and our views may have changed since then. Unless otherwise stated estimates, including prospective yields, are a consensus of analyst forecasts provided by Refinitiv. These estimates are not a reliable indicator of future performance. Yields are variable and not guaranteed. Investments rise and fall in value so investors could make a loss.

This article is not advice or a recommendation to buy, sell or hold any investment. No view is given on the present or future value or price of any investment, and investors should form their own view on any proposed investment. This article has not been prepared in accordance with legal requirements designed to promote the independence of investment research and is considered a marketing communication. Non-independent research is not subject to FCA rules prohibiting dealing ahead of research, however HL has put controls in place (including dealing restrictions, physical and information barriers) to manage potential conflicts of interest presented by such dealing. Please see our full non-independent research disclosure for more information.


Previous Reckitt Benckiser Group Plc updates

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used.

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.